CAJ | 학술논문

甲状腺髓样癌（ medullary thyroid carcinoma， MTC）为相对少见的恶性肿瘤之一，约占所有甲状腺癌的3％～5％，其组织来源为甲状腺滤泡旁细胞。 MTC细胞能够产生降钙素（ calcitonin）和其他具有内分泌活性的物质，其临床表现可有腹泻、潮红等类癌综合征或内分泌失调的表现，治疗上主张甲状腺全切除术，故不同于其他类型甲状腺癌。本文就MTC的外科治疗进展作一综述。
갑상선수양암（ medullary thyroid carcinoma， MTC）위상대소견적악성종류지일，약점소유갑상선암적3％～5％，기조직래원위갑상선려포방세포。 MTC세포능구산생강개소（ calcitonin）화기타구유내분비활성적물질，기림상표현가유복사、조홍등유암종합정혹내분비실조적표현，치료상주장갑상선전절제술，고불동우기타류형갑상선암。본문취MTC적외과치료진전작일종술。
Medullary thyroid cancer ( MTC) derives from thyroid parafollicular cells in histology and is a relatively un-common malignant tumor, accounting for 3%~5%of all thyroid carcinomas.MTC cells can produce calcitonin and other endocrine active substances.The clinical manifestations may have diarrhea, flushing and other carcinoid syndrome or endo-crine disorders.Total thyroidectomy is recommended for treatment.So its clinical symptoms and treatments are different from other types of thyroid carcinoma.This article will review the progression in surgical treatment of MTC.